Zacks Investment Research
19 May 2026, 14:55 UTC · 2d ago
Source · https://www.zacks.com/stock/news/2923360/wall-street-analysts-believe-corcept-cort-could-rally-43-32-here-s-is-how-to-trade?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|consensus_price_target-2923360
Read source
Search tags
Story key points
2 claims · impact-rated
Analysts have revised their earnings estimates for Corcept Therapeutics (CORT) upward. — Positive earnings revisions are generally a strong signal for stock price appreciation and reflect improving fundamental expectations.
+0.40The mean analyst price target for CORT is $79, representing a 43.3% potential upside from its last close of $55.12. — While price targets suggest growth potential, the article explicitly warns that they are often inflated due to analyst bias.
+0.20Impact vectors
4 dimensions · 9 clusters
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Ticker attribution
Model heads
The stock has gained 19% recently and analysts suggest significant upside potential with a mean price target of $79.
No ticker relationship head found.
